Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma

被引：5

作者：

Sun Fu-kang ^{[1
]}

He Hong-chao ^{[1
]}

Su Ting-wei ^{[2
]}

Zhou Wen-long ^{[1
]}

Huang Xin ^{[1
]}

Dai Jun ^{[1
]}

Shen Zhou-jun ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Urol, Shanghai 200025, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Endocrinol,Clin Ctr Shanghai Endocrine & Met, Shanghai 200025, Peoples R China

来源：

CHINESE MEDICAL JOURNAL | 2012年 / 125卷 / 12期

关键词：

sunitinib; targeted therapy; anti-angiogenesis; malignant pheochromocytoma; EFFICACY;

D O I：

10.3760/cma.j.issn.0366-6999.2012.12.027

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Sporadic malignant pheochromocytoma, a rare disease with poor prognosis, is always difficult to treat due in part to lack of effective agents. We presented three patients with advanced malignant pheochromocytoma treated by sunitinib, which indicates that sunitinib is an effective agent for this malignancy.

引用

页码：2231 / 2234

页数：4

共 50 条

[1] Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review
AboulMagd, Asmaa M.
Abdelwahab, Nada S.
MICROCHEMICAL JOURNAL, 2021, 163
[2] Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib
Huang, Qiang
Zhou, Changhua
Chen, Xiao
Dong, Bing
Chen, Siqi
Zhang, Ning
Liu, Yawei
Li, Anrong
Yao, Meicun
Miao, Ji
Li, Qing
Wang, Zhong
PLOS ONE, 2015, 10 (10):
[3] Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib
Chung, Caroline
Dawson, Laura A.
Joshua, Anthony M.
Brade, Anthony M.
ANTI-CANCER DRUGS, 2010, 21 (02) : 206 - 209
[4] A novel selective multi-targeted tyrosine kinase inhibitor with superior anti-tumor efficacy
Hjarnaa, P.
Fensholdt, Jef
INFLAMMATION RESEARCH, 2007, 56 : S464 - S465
[5] TKI258, a novel, multi-targeted tyrosine kinase inhibitor for the treatment of breast cancer
Liu, Hongyu
Dieing, Annette
Lehenbauer-Dehm, Sylvia
Kuehnhardt, Dagmar
Regierer, Anne
Schulz, Carsten
Storek, Benjamin
Schwarck, Sandra
Possinger, Kurt
Eucker, Jan
CANCER RESEARCH, 2009, 69
[6] A multi-targeted tyrosine kinase inhibitor lenvatinib for the treatment of mice with advanced glioblastoma
Li, Jia
Zou, Chang-Lin
Zhang, Zhi-Ming
Lv, Lian-Jie
Qiao, Hai-Bo
Chen, Xiu-Ju
MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 7105 - 7111
[7] Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib
Noppadon Kongsuphon
Maturos Soukavanitch
Noramon Teeraaumpornpunt
Jitprapa Konmun
Touch Ativitavas
Nuttapong Ngamphaiboon
Journal of Gastrointestinal Cancer, 2019, 50 : 601 - 603
[8] Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib
Kongsuphon, Noppadon
Soukavanitch, Maturos
Teeraaumpornpunt, Noramon
Konmun, Jitprapa
Ativitavas, Touch
Ngamphaiboon, Nuttapong
JOURNAL OF GASTROINTESTINAL CANCER, 2019, 50 (03) : 601 - 603
[9] Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
Broekman, Fleur
Giovannetti, Elisa
Peters, Godefridus J.
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (02): : 80 - 93
[10] The multi-targeted kinase inhibitor Sunitinib induces apoptosis in colon cancer cells via PUMA
Sun, Jing
Sun, Quanhong
Brown, Matthew F.
Dudgeon, Crissy
Chandler, Julie
Zhang, Lin
Yu, Jian
CANCER RESEARCH, 2012, 72

← 1 2 3 4 5 →